Literature DB >> 4352254

Cell-mediated immunity to Varicella-Zoster antigen in acute Herpes zoster (shingles).

A S Russell, R A Maini, M Bailey, D C Dumonde.   

Abstract

Mesh：

Substances：

Year:  1973        PMID： 4352254      PMCID： PMC1553793     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  17 in total

1.  THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS.

Authors:  R E HOPE-SIMPSON
Journal:  Proc R Soc Med       Date:  1965-01

Review 2.  Recurrent viral infection (reinfection).

Authors:  T W Chang
Journal:  N Engl J Med       Date:  1971-04-08       Impact factor: 91.245

3.  Laboratory studies on the varicella-zoster virus.

Authors:  E V Meurisse
Journal:  J Med Microbiol       Date:  1969-08       Impact factor: 2.472

4.  Zoster, reinfection or activation of latent virus? Observations on the antibody response.

Authors:  L H Miller; P A Brunell
Journal:  Am J Med       Date:  1970-10       Impact factor: 4.965

5.  Cutaneous interferon production in patients with Hodgkin's disease and other cancers infected with varicella or vaccinia.

Authors:  R W Armstrong; M J Gurwith; D Waddell; T C Merigan
Journal:  N Engl J Med       Date:  1970-11-26       Impact factor: 91.245

6.  An immunological approach to ageing.

Authors:  F M Burnet
Journal:  Lancet       Date:  1970-08-15       Impact factor: 79.321

7.  Characteristics of herpes zoster and varicella viruses propagated in vitro.

Authors:  E Gold
Journal:  J Immunol       Date:  1965-10       Impact factor: 5.422

8.  Prevention of varicella by zoster immune globulin.

Authors:  P A Brunell; A Ross; L H Miller; B Kuo
Journal:  N Engl J Med       Date:  1969-05-29       Impact factor: 91.245

9.  Long-term cyclophosphamide therapy in rheumatoid arthritis.

Authors:  W M Fosdick; J L Parsons; D F Hill
Journal:  Arthritis Rheum       Date:  1968-04

10.  Long survival in Hodgkin's disease.

Authors:  P L Chawla; L Stutzman; R E Dubois; U Kim; J E Sokal
Journal:  Am J Med       Date:  1970-01       Impact factor: 4.965
View more
  9 in total

1.  Cellular and humoral immune responses to varicella-zoster virus in immunocompromised patients during and after varicella-zoster infections.

Authors:  A A Gershon; S P Steinberg
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

2.  Cell-mediated immunity to varicella-zoster virus measured by virus inactivation: mechanism and blocking of the reaction by specific antibody.

Authors:  A A Gershon; S P Steinberg
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

3.  Cell-mediated immunity to Herpes simplex in humans: lymphocyte cytotoxicity measured by 51-Cr release from infected cells.

Authors:  A S Russell; J S Percy; T Kovithavongs
Journal:  Infect Immun       Date:  1975-02       Impact factor: 3.441

4.  The role of membrane association of antigens in induction of cell-mediated immunity to viruses.

Authors:  M W Rytel; R A Niebojewski
Journal:  Clin Exp Immunol       Date:  1978-05       Impact factor: 4.330

5.  Stimulation of peripheral blood lymphocytes by herpes simplex virus in vitro.

Authors:  M Scriba
Journal:  Infect Immun       Date:  1974-09       Impact factor: 3.441

6.  Cell-mediated and humoral immunity to herpesviruses during and after herpes zoster infections.

Authors:  O S Sørensen; S Haahr; A Møller-Larsen; K Wildenhoff
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

7.  Suppression of cellular immune responses in guinea pigs infected with spotted fever group rickettsiae.

Authors:  C N Oster; R H Kenyon; C E Pedersen
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

8.  Cell-mediated immunity to varicella-zoster virus demonstrated by viral inactivation with human leukocytes.

Authors:  A A Gershon; S Steinberg; M Smith
Journal:  Infect Immun       Date:  1976-06       Impact factor: 3.441

9.  Lymphocyte transformation induced by autologous cells. VIII. Impaired autologous mixed lymphocyte reactivity in patients with acute infectious mononucleosis.

Authors:  C E Moody; B A Casazza; W N Christenson; M E Weksler
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.